Reduction of Symptoms by Valacyclovir in Cytomegalovirus-Seropositive Individuals With Schizophrenia
Authors:
- John J. BoronowJBJohn J. Boronow
- Cassie R. StallingsCSCassie R. Stallings
- Andrea E. OrigoniAOAndrea E. Origoni
- Robert H. YolkenRYRobert H. Yolken
- 1 December 2003
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 160 (12) , 2234-2236
Abstract
OBJECTIVE: The study was an investigation of the effect of the antiviral medication valacyclovir on the symptoms of outpatients with persistent schizophrenia. METHOD: Oral valacyclovir, 1 g twice d...Keywords
This publication has 9 references indexed in Scilit:
- Maternal Infections and Subsequent Psychosis Among OffspringArchives of General Psychiatry, 2001
- ValaciclovirDrugs, 2000
- Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: Implications for schizophreniaJournal of Neuroscience Research, 1999
- Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment RecommendationsSchizophrenia Bulletin, 1998
- ValaciclovirDrugs, 1996
- Viruses, schizophrenia, and bipolar disorderClinical Microbiology Reviews, 1995
- Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different testsJournal of Virological Methods, 1987
- Failure to alleviate symptoms of schizophrenia with the novel use of an antiviral agent, acyclovir (Zovirax)Biological Psychiatry, 1987
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987